Wednesday, October 15, 2014 4:08:49 PM
Gross margin hit a high since Q2 2012 at 65.3%. last few quarters have been in the 58-61% range.
Bad:
Sales are down 5% over the prior quarter, Q1.
Expenses has risen as fast as cash. We can see this is in the SG&A and R&D.
Trailing 4Q has EPS of $.024. Put a 20x on that you get a $.48/share value. good.
Last 2Q with very good sales only has $.01 or $.02. Trading at 18x.
They have spent an extra $240k in SG&A and R&D in Q2 vs Q2 2013. If we had SG&A at Q2 2013 levels we would have had sales of $.012 for the quarter vs $.005/quarter. If we had Q2 2012 expenses we would have had $.02/share of earnings.
They got the markets attention by jumping their sales in Q4 2013 (Feb 28, 2014) by going up 25%. Since then they have flatlined and more negatively their expenses have grown faster than revenues. When I worked in mfg. we had a mandate to grow fixed expenses no faster than 70% of topline growth. That was manageable. I gave last quarter a pass. I can't again.
I'm not adding but holding.
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM